	Ebitda		Date
Acadia Pharmaceuticals	USD 35.76M	447K	2025-09
Akebia Therapeutics	USD 14.03M	17.19M	2025-03
ALKERMES	USD 121.55M	4.99M	2025-09
Alnylam Pharmaceuticals	USD 145.22M	236.56M	2025-12
Amarin	USD 12.54M	28.57M	2025-06
ANI Pharmaceuticals	USD 59.6M	5.52M	2025-09
BioMarin Pharmaceutical	USD 295.45M	49.49M	2025-06
Coherus Biosciences	USD -44.34M	9.82M	2025-03
Exact Sciences	USD 135.42M	2.8M	2025-09
Exelixis	USD 248.93M	28.02M	2025-09
Glaxosmithkline	GBP 4.75B	1.52B	2025-09
Heron Therapeutics	USD -3.88M	5.63M	2024-09
Ionis Pharmaceuticals	USD -157.12M	307.36M	2025-09
Ironwood Pharmaceuticals	USD 81.81M	31.71M	2025-09
Lonza	CHF 1.01B	54M	2025-12
Merck	USD 8.39B	1.97B	2025-09
Moderna	USD -790M	582M	2025-12
Myriad Genetics	USD 10.3M	4.2M	2025-09
Nektar Therapeutics	USD -31.81M	70K	2023-09
Neurocrine Biosciences	USD 218.4M	28.3M	2025-12
Pacira	USD 49.36M	4.96M	2025-09
Pfizer	USD 6.08B	351M	2025-09
PTC Therapeutics	USD -33.11M	1B	2025-06
Sanofi	EUR 4.84B	2.95B	2025-09
Sarepta Therapeutics	USD 126.42M	416.82M	2025-06
United Therapeutics	USD 436.8M	34.2M	2025-06
Vanda Pharmaceuticals	USD -8.31M	2.37M	2024-12
Xoma	USD 2.52M	7.98M	2024-06

Emergent BioSolutions - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.